HER2-Negative Breast Cancer Terminated Phase 1 Trials for Letrozole (DB01006)

IndicationStatusPhase
DBCOND0072181 (HER2-Negative Breast Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01208441RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast CancerTreatment